-
Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure
Yang S, Yu Y, Xu Y, Jian F, Song W, Yisimayi A, Wang P, Wang J, Liu J, Yu L, Niu X, Wang J, Wang Y, Shao F, Jin R, Wang Y, Cao Y. Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure. Lancet Infect Dis. 2024 Feb;24(2):e70-e72. doi: 10.1016/S1473-3099(23)00744-2. Epub 2023 Dec 15. Erratum in: Lancet Infect Dis. 2024 Mar;24(3):e156. doi: 10.1016/S1473-3099(23)00822-8. PMID: 38109919. -
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting
Yisimayi A, Song W, Wang J, Jian F, Yu Y, Chen X, Xu Y, Yang S, Niu X, Xiao T, Wang J, Zhao L, Sun H, An R, Zhang N, Wang Y, Wang P, Yu L, Lv Z, Gu Q, Shao F, Jin R, Shen Z, Xie XS, Wang Y, Cao Y. Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting. Nature. 2024 Jan;625(7993):148-156. doi: 10.1038/s41586-023-06753-7. Epub 2023 Nov 22. PMID: 37993710; PMCID: PMC10764275. -
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants
Yang J, Hong W, Shi H, Wang Z, He C, Lei H, Yan H, Alu A, Ao D, Chen Z, Zhou Y, Yang H, Yang Y, Yu W, Tang C, Wang J, Li B, Huang Q, Hu H, Cheng W, Dong H, Lei J, Chen L, Zhou X, Yang L, Wang W, Shen G, Yang J, Zhao Z, Song X, Sun Q, Wang Y, Lu S, Li J, Lu G, Li W, Wei Y, Wei X. A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants. Signal Transduct Target Ther. 2025 Feb 26;10(1):58. doi: 10.1038/s41392-025-02154-6IF: 40.8 Q1 . PMID: 400006 -
Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials.
Yang J, Hong W, Shi H, He C, Lei H, Zhou Y, Yang H, Alu A, Chen Z, Yang Y, Yu W, Tang C, Wang J, Li B, Huang Q, Li J, Yang L, Wang W, Shen G, Yang J, Zhao Z, Song X, Su Z, Wei Y, Sun Q, Lu S, Wang Z, Wang Y, Lu G, Li W, Wei X. Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials. Nat Commun. 2024 Dec 30;15(1):10778. doi: 10.1038/s41467-024-55087-z. PMID: 39738039; PMCID: PMC11686202. -
Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variants
Lei H, Hong W, Yang J, He C, Zhou Y, Zhang Y, Alu A, Shi J, Liu J, Qin F, Ao D, Huang X, Chen Z, Yang H, Yang Y, Yu W, Tang C, Wang J, Li B, Huang Q, Hu H, Cheng W, Dong H, Lei J, Chen L, Zhou X, Li J, Yang L, Wang Z, Wang W, Shen G, Yang J, Zhao Z, Song X, Lu G, Sun Q, Wang Y, Lu S, Wei X. Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variants. Signal Transduct Target Ther. 2024 Nov 20;9(1):311. doi: 10.1038/s41392-024-02025-6. PMID: -
Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1
An R, Yang H, Tang C, Li Q, Huang Q, Wang H, Wang J, Zhou Y, Yang Y, Chen H, Yu W, Li B, Wu D, Zhang Y, Luo F, Quan W, Xu J, Lin D, Liang X, Yan Y, Yuan L, Du X, Yuan Y, Li Y, Sun Q, Wang Y, Lu S. A protein vaccine of RBD integrated with immune evasion mutation shows broad protection against SARS-CoV-2. Signal Transduct Target Ther. 2024 Nov 6;9(1):301. doi: 10.1038/s41392-024-02007-8. PMID: 39500906; PMCID: PMC11538548. -
A protein vaccine of RBD integrated with immune evasion mutation shows broad protection against SARS-CoV-2
Niu X, Li Z, Wang J, Jian F, Yu Y, Song W, Yisimayi A, Du S, Zhang Z, Wang Q, Wang J, An R, Wang Y, Wang P, Sun H, Yu L, Yang S, Xiao T, Gu Q, Shao F, Wang Y, Xiao J, Cao Y. Omicron-specific ultra-potent SARS-CoV-2 neutralizing antibodies targeting the N1/N2 loop of Spike N-terminal domain. Emerg Microbes Infect. 2024 Dec;13(1):2412990. doi: 10.1080/22221751.2024.2412990. Epub 2024 Oct 28. PMID: 39361729; PMCID: PMC11520098. -
Prolonged Omicron-specific B cell maturation alleviates immune imprinting induced by SARS-CoV-2 inactivated vaccine
Yisimayi A, Song W, Wang J, Jian F, Yu Y, Chen X, Xu Y, An R, Wang Y, Wang J, Sun H, Wang P, Yu L, Shao F, Jin R, Shen Z, Wang Y, Cao Y. Prolonged Omicron-specific B cell maturation alleviates immune imprinting induced by SARS-CoV-2 inactivated vaccine. Emerg Microbes Infect. 2024 Dec;13(1):2412623. doi: 10.1080/22221751.2024.2412623IF: 8.4 Q1 . Epub 2024 Oct 15. PMID: 39360822; PMCID: PMC11486138. -
Antigenic analysis of the influenza B virus hemagglutinin protein
Zhang M, Yang C, Wu X, Wang Y, Wang L, Cui Q, Tong J, An Y, Cai M, Cheng S, Jiang Q, Wang Y, Zhao C, Wang Y, Huang W. Antigenic analysis of the influenza B virus hemagglutinin protein. Virol Sin. 2024 Sep 2:S1995-820X(24)00139-1. doi: 10.1016/j.virs.2024.08.012. Epub ahead of print. PMID: 39233140. -
Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity
Liu P, Yue C, Meng B, Xiao T, Yang S, Liu S, Jian F, Zhu Q, Yu Y, Ren Y, Wang P, Li Y, Wang J, Mao X, Shao F, Wang Y, Gupta RK, Cao Y, Wang X. Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity. Natl Sci Rev. 2024 Jun 14;11(7):nwae206. doi: 10.1093/nsr/nwae206. PMID: 39071099; PMCID: PMC11282955.